While safety data is encouraging, with no significant differences in adverse events compared to placebo, a larger Phase IV outcomes trial is ongoing to confirm the long-term cardiovascular benefits of enlicitide, and Merck has initiated the FDA approval process, with the drug in the fast track program
Stopping semaglutide doesn't erase the progress you've mademany patients maintain weight loss through sustained lifestyle changes after stopping the medication
Understanding these potential effects empowers patients to make informed decisions about their health while taking proactive steps to protect their smiles during treatment
Upper Respiratory Tract Infection: Similar to a cold, but may involve more sinus congestion or a cough
Abrams BF, Leonard SA, Kan P, Lyell DJ, Carmichael SL
Who is NAC recommended for